WHAT IT’S FOR The firm also built a vaccine booking system, which has been used to manage more than 21 million vaccinations. The newly raised funds will allow accuRx to continue growing its team and building products that will enable expansion into secondary care.
The startup’s vision is that anyone involved in a patient’s care can communicate with each other. Founded in 2016, accuRx’s mission is to bring patients and their healthcare teams together. Its platform is used by 98% of GP practices in England and some secondary care providers.
During the pandemic, accuRx introduced a video interface which facilitated remote consultations and surveys to allow remote monitoring of patients with COVID-19 symptoms. WHAT IT DOES
ON THE RECORD Dr David Triska, GP partner at Witley and Milford Surgeries, said: “accuRx’s product has reinvigorated communication with our patients, enabling a better relationship between GPs and patients, which has ultimately led to better care provision. Meanwhile, London-based healthtech company Abtrace recently announced it has raised £2.1 million in seed funding. The startup’s AI technology for management of long-term health conditions automates key elements of disease monitoring, allowing GPs and healthcare assistants to make informed decisions.
THE LARGER CONTEXT It plans to develop system-wide infrastructure that allows for NHS communication outside of GP systems such as accuRx Web, which currently has 11,000 weekly active users in non-GP settings including hospitals, pharmacies, and care homes.
The News Highlights
- British healthcare platform accuRx hits £27.5 million in Series B round
- Check the latest Health news updates and information about health.
For Latest News Follow us on Google News
- Show all
- Trending News
- Popular By week